Pendekatan Klinis Sindrom Takotsubo

Tinjauan Pustaka

Penulis

DOI:

https://doi.org/10.55175/cdk.v53i06.1349

Kata Kunci:

Infark miokard, kardiomiopati, sindrom Takotsubo, stres

Abstrak

Sindrom Takotsubo (TTS) atau kardiomiopati akibat stres didefinisikan sebagai sindrom disfungsi sistolik dan diastolik ventrikel kiri sementara dan akut yang biasanya terkait dengan stres emosional atau fisik mendalam. Insiden sindrom Takotsubo meningkat dramatis selama pandemic COVID-19 yang erat kaitannya dengan stresor psikologis seperti isolasi sosial, masalah finansial, dan kecemasan. Peningkatan stimulasi simpatetik dengan pelepasan catecholamine secara masif memainkan peran utama dalam patogenesis kardiomiopati Takotsubo. Anamnesis akurat peristiwa emosional dan fisik sebelum timbulnya gejala merupakan alat diagnostik yang paling penting. Pada fase akut, sebagian besar keluhan pasien adalah nyeri dada khas yang tidak dapat dibedakan dari infark miokard, gejala lain berupa gejala gagal jantung seperti dyspnea, orthopnea, dan/atau edema paru akut atau sinkop. Penanda klinis penting kardiomiopati Takotsubo adalah peningkatan N-terminal prohormone of brain natriuretic peptide (NT proBNP), yang telah terbukti terkait langsung dengan peningkatan konsentrasi catecholamine dalam darah sebagai penanda reaksi berlebihan simpatis dan tingkat keparahan disfungsi ventrikel kiri dengan komplikasi sistemik terkait, seperti edema paru. Pengobatan suportif dan simtomatik harus diberikan pada fase akut. Pasien kardiomiopati Takotsubo memiliki prognosis baik dengan fungsi ventrikel kiri dapat mulai pulih dalam beberapa hari dan pulih sepenuhnya dalam 3–4 minggu.

Unduhan

Data unduhan belum tersedia.

Referensi

Bairashevskaia AV, Belogubova SY, Kondratiuk MR, Rudnova DS, Sologova SS, Tereshkina OI, et al. Update of Takotsubo cardiomyopathy: present experience and outlook for the future. IJC Heart & Vasculature. 2022;39:1–16. https://doi.org/10/1016/j.ijcha.2022.100990.

Matta A, Delmas C, Campelo-Parada F, Lhermusier T, Bouisset F, Elbaz M, et al. Takotsubo cardiomyopathy. Rev Cardiovasc Med. 2022;23(1):1–8. http://doi.org/10.31083/j.rcm2301038.

Assad J, Femia G, Pender P, Badie T, Rajaratnam R. Takotsubo syndrome: a review of presentation, diagnosis, and management. Clin Med Insights Cardiol. 2022;16:1–11. doi: 10.1177/11795468211065782.

Zghyer F, Botheju WSP, Kiss JE, Michos ED, Corretti MC, Mukherjee M, et al. Cardiovascular imaging in stress cardiomyopathy (Takotsubo syndrome). Front Cardiovasc Med. 2022;8:1–13. doi: 10.3389/fcvm.2021.799031.

Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145(13):1002–19. doi:10.1161/CIRCULATIONAHA.121.055854.

Matta AG, Carrie D. Epidemiology, pathophysiology, diagnosis, and principles of management of takotsubo cardiomyopathy: a review. Med Sci Monitor. 2023;29:1–5. doi: 10.12659/MSM.939020.

Roncalli J, Carrie D, Fauvel JM, Losordo D. A “hak’s beak” to identify the new transient midventricular Tako-Tsubo syndrome. Internat J Cardiol. 2008;127:179–80.

Pasupula DK, Patthipati VS, Javed A, Siddappa Malleshappa SK. Takotsubo cardiomyopathy: understanding the pathophysiology of selective left ventricular involvement. Cureus. 2019;11(10):1–5. doi: 10.7759/cureus.5972.

Ghadri JR, Cammann VL, Jurisic S, Seifert B, Napp LC, Diekmann J, et al. A novel clinical score (InterTAK diagnostic score) to differentiate Takotsubo syndrome from acute coronary syndrome: results from the international Takotsubo registry. Eur J Heart Fail. 2019;19:1036–42.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032–46. doi:10.1093/eurheartj/ehy076.

Buchmann SJ, Lehmann D, Stevens CE. Takotsubo cardiomyopathy—acute cardiac dysfunction associated with neurological and psychiatric disorders. Front Neurol. 2019;10(AUG):1–8. doi: 10.3389/fneur.2019.00917.

Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, et al. Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8–27. doi:10.1002/ejhf.424.

Amin HZ, Amin LZ, Pradipta A. Takotsubo cardiomyopathy: a brief review. J Med Life. 2020;13(1):3–7. doi: 10.25122/jml-2018-0067.

Barmore W, Patel H, Harrell S, Garcia D, Jr JBC. Takotsubo cardiomyopathy: a comprehensive review. World J Cardiol. 2022;14(6):355–62. doi: 10.4330/wjc.v14.i6.355.

Kurisu S, Sato H, Kawagoe T, Ishihara M, Nishioka K. Takotsubo- like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143:448–55.

Abanador-Kamper N, Kamper L, Wolfertz J, Pomjanski W, Wolf-Putz A, Seyfarth M. Evaluation of therapy management and outcome in Takotsubo syndrome. BMC Cardiovasc Disord. 2017;17(225):1–9.

Almendro-Delia M, Nunez-Gil UJ, Lobo M, Andres M, Vedia O, Sionis A. Short-and long-term prognostic relevance of cardiogenic shock in Takotsubo syndrome: results from the REKATOregistry. JACC Heart Fail. 2018;6:928–36. doi: 10.1016/j.jchf.2018.05.015.

Unduhan

Diterbitkan

2026-06-15

Cara Mengutip

Pramudya, R. (2026). Pendekatan Klinis Sindrom Takotsubo: Tinjauan Pustaka. Cermin Dunia Kedokteran, 53(06), 433–442. https://doi.org/10.55175/cdk.v53i06.1349

Terbitan

Bagian

Articles